Screening Assessment Report

Pseudomonas stutzeri
American Type Culture Collection (ATCC) 17587

Environment Canada
Health Canada
January 2015

(PDF Format - 690 KB)

Table of Contents

List of Tables

List of Figures

Synopsis

Pursuant to paragraph 74(b) of the Canadian Environmental Protection Act, 1999 (CEPA 1999), the Minister of the Environment and the Minister of Health have conducted a screening assessment of P. stutzeri ATCC 17587.

P. stutzeri ATCC 17587 is a bacterium that has characteristics in common with other strains of the species P. stutzeri that occur in nature. P. stutzeri has the ability to adapt to and thrive in soil, sediments and water. Multiple potential uses of P. stutzeri in household, industrial, commercial and agricultural sectors exist. These include treatment of ponds and aquariums (to breakdown wastes and control odours), waste management, wastewater treatment, septic tank cleaning and deodorizing, drain cleaning and degreasing, bioremediation, recovery of oil and precious metals, as well as in enzyme production for the manufacture of foods, detergents, textiles and bioethanol.

Despite the widespread presence of P. stutzeri in soil and water and in close association with plant roots, only one case of infection has been reported in terrestrial vertebrates. This case was in chickens, and the infection was successfully treated with antibiotics. Certain strains of P. stutzeri have antialgal, antibacterial and antifungal properties. Experimental challenge with P. stutzeri ATCC 17587 on a soil springtail, a terrestrial invertebrate, revealed a significant decrease in adult survival and juvenile production at concentrations which can be reached during bioremediation uses. However, there is no evidence that occasional applications of P. stutzeri ATCC 17587 to soil will adversely affect terrestrial invertebrates at the population level.

There have been no human infections attributed to the DSL strain P. stutzeri ATCC 17587. Some strains of P. stutzeri can act as an opportunistic pathogen in susceptible humans. Compared with other closely-related opportunistic Pseudomonas pathogens, the incidence of nosocomial or secondary infection due to P. stutzeri in individuals with compromised immunity and underlying medical conditions is low.

This assessment considers the aforementioned characteristics of P. stutzeri ATCC 17587 with respect to environmental and human health effects associated with product use and industrial processes subject to CEPA 1999, including releases to the environment through waste streams and incidental human exposure through environmental media. To update information about current uses, the Government launched a mandatory information-gathering survey under section 71 of CEPA 1999 (section 71 notice) as published in the Canada Gazette, Part I, on October 3, 2009. Information submitted in response to the notice indicates that P. stutzeri ATCC 17587 was not imported into or manufactured in Canada in 2008.

Considering all available lines of evidence presented in the Screening Assessment, there is a low risk of harm to organisms and the broader integrity of the environment from P. stutzeri ATCC 17587. It is concluded that P. stutzeri ATCC 17587 does not meet the criteria under paragraph 64(a) or (b) of CEPA 1999 as it is not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity or that constitute or may constitute a danger to the environment on which life depends.

Also, based on the information presented in the Screening Assessment, it is concluded that P. stutzeri ATCC 17587 does not meet the criteria under paragraph 64(c) of CEPA 1999 as it is not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.

Top of Page

Introduction

Pursuant to paragraph 74(b) of the Canadian Environmental Protection Act, 1999 (CEPA 1999), the ministers of Environment and of Health are required to conduct Screening Assessments of those living organisms listed on the Domestic Substances List (DSL) which were in commerce between 1984 and 1986, to determine whether they present or may present a risk to the environment or human health (according to criteria as set out in section 64 of CEPA 1999).Footnote[1] Pseudomonas stutzeri ATCC 17587 was added to the DSL under subsection 105(1) of CEPA 1999 because it was manufactured in or imported into Canada between January 1, 1984, and December 31, 1986, and entered or was released into the environment without being subject to conditions under CEPA 1999 or any other federal or provincial legislation.

This Screening Assessment considers hazard information obtained from the public domain and from unpublished research data, as well as comments from scientific peer reviewers. Exposure information was obtained from the public domain and from a mandatory CEPA 1999 section 71 Notice published in the Canada Gazette Part 1 on October 3, 2009. Further details on the risk assessment methodology used are available in the Risk Assessment Framework document entitled “Framework on the Science-Based Risk Assessment of Micro-organisms under the Canadian Environmental Protection Act, 1999” (Environment Canada and Health Canada, 2011).

In this report, data that are specific to DSL-listed P. stutzeri ATCC 17587 are identified as such. Where strain-specific data were not available, surrogate information from literature searches was used. When applicable, literature searches conducted on the organism included its synonyms, and common and superseded names. Surrogate organisms are identified in each case to the taxonomic level provided by the source. Literature searches were conducted using scientific literature databases (SCOPUS, CAB Abstracts, and NCBI), web searches, and key search terms for the identification of human health and environmental hazards. Information identified up to August 2013 was considered for inclusion in this Screening Assessment Report.

Top of Page

Decisions from Domestic and International Jurisdictions

Domestic

The Public Health Agency of Canada (PHAC) assigned P. stutzeri (as a species) to Risk Group 1 for both humans and terrestrial animals (personal communication, PHAC 2013).

The Canadian Food Inspection Agency (CFIA) does not consider P. stutzeri as a regulated plant pest in Canada (personal communication, CFIA 2013).

International

No information found.

Top of Page

1. Hazard Assessment

1.1 Characterization of Pseudomonas stutzeri

1.1.1 Taxonomic identification and strain history

Binomial name Pseudomonas stutzeri(P. stutzeri)
Taxonomic designation
Kingdom
Bacteria
Phylum Proteobacteria
Class Gammaproteobacteria
Order Pseudomonadales
Family Pseudomonadaceae
Genus Pseudomonas
Species stutzeri (Lehmann and Neumann, 1896) Sijderius 1946 (validated 1980)
Strain ATCC 17587 (equivalent to LMG 5838, NCPPB 1972,
Lautrop AB180, Stanier 220)

Superseded names:  "Bacillusdenitrificans II" (Burri and Stutzer, 1895); "Bacterium stutzeri" (Lehmann and Neumann, 1896); "Bacillus nitrogenes" (Migula, 1900); "Bacillus stutzeri" (Chester, 1901); "Achromobacter sewerinii" (Bergey et al., 1923); "Achromobacter stutzeri" (Bergey et al., 1930); "Pseudomonas stanieri" (Mandel, 1966).

Strain history

P. stutzeri ATCC 17587 was originally isolated from a clinical specimen (bile) in 1956 at Statens Seruminstitut, Copenhagen, Denmark, by Dr. H. Lautrop and designated as Lautrop strain AB 180 (reviewed in NCPPB, 2013; Rainey et al., 1994; Stanier et al., 1966). The strain was received by Dr. R.Y. Stanier and designated as Stanier 220 (Stanier et al., 1966) and deposited to the American Type Culture Collection as ATCC accession number 17587. The strain was also deposited to the National Collection of Plant Pathogenic Bacteria as NCPPB 1972 (NCPPB, 2013).

1.1.2 Phenotypic and molecular characteristics

P. stutzeri is markedly heterogeneous, making each strain difficult to differentiate from another on the basis of morphology, biochemical and nutritional properties alone (reviewed in Cladera et al., 2004; Lalucat et al., 2006). Species diversity, however, has been established with the subdivision of P. stutzeri intodistinct genomic groups, commonly referred to asgenomovars (Rosselló-Mora et al., 1991). There are currently 22 genomovars assigned to the species (Scotta et al., 2013). This grouping allows for clustering of P. stutzeristrains that cannot be distinguished phenotypically from others (Rosselló-Mora et al., 1991; Cladera et al., 2005). Based on the taxonomic standard for species delineation (Roselló-Mora and Amann, 2001; Stackebrandt et al., 2002), members of the same P. stutzeri genomovar are grouped based on DNA-DNA hybridization values greater than 70% (Rosselló-Mora et al., 1991; reviewed in Cladera et al., 2004; Lalucat et al., 2006; Sikorski et al., 2005). These hybridization values are usually less than 50% when strains from different genomovars are compared (Rosselló-Mora et al., 1991; Garcia-Valdes et al., 2010).

Comparisons of morphological, biochemical and molecular properties between P. stutzeri  ATCC 17587, P. stutzeri ATCC 17591 (genomovar 2 reference strain clinical isolate) and P. stutzeri ATCC 17588 (genomovar 1 type strain clinical isolate) are summarized in Tables 1-1, 1-2, 1-3 and 1-4. Characteristics that differentiate P. stutzeri from its closest pathogenic relatives, P. aeruginosa and P. fluorescens, are also noted in the following tables.

Table 1-1 Morphological properties of P. stutzeri
Characteristic P. stutzeri ATCC 17587
(DSL strain)
genomovar 2
P. stutzeri ATCC 17591
(reference strain)
genomovar 2
P. stutzeri ATCC 17588
(type strain)
genomovar 1
Gram staining NegativeFootnote Table 1-1 [a] NegativeFootnote Table 1-1 [b] Negative[b]
Fluorescent No[a],Footnote Table 1-1[c] No[b] No[a],[c]
Colonies Colony morphologies vary with different
nutrient media and culture conditions[a]
Translucent colonies with entire margin[b] Freshly isolated: wrinkled, resemble craters with elevated ridges (coral structure),
reddish brown, hard, dry, tenacious

Older colonies: smooth, butyraceous, pale
(Lalucat et al., 2006)
Motility Yes[a] Yes (Rosselló-Mora et al., 1991) Yes[b]
Table 1-2 Growth and biochemical properties of P. stutzeri
Characteristic P. stutzeri ATCC 17587
(DSL strain)
genomovar 2
P. stutzeri ATCC 17591
(reference strain)
genomovar 2
P. stutzeri ATCC 17588
(type strain)
genomovar 1
Growth at 42°C NoFootnote Table 1-2 [a] No[a] YesFootnote Table 1-2 [b]
Catalase PositiveFootnote Table 1-2 [c] Positive[b] Positive[b]
Oxidase Positive[c] Positive[b] Positive[b]
Starch hydrolysis Positive[c],Footnote Table 1-2[d] Positive[b] Positive[b],[d]
Gelatin hydrolysis Negative[c],[d] Negative[b]b Negative[b],[d]
Denitrification Positive[c] Positive (Grüntzig et al., 2001) Positive[b]
Table 1-3 P. stutzeri assimilation of select substrates
Substrate P. stutzeri ATCC 17587
(DSL strain)
genomovar 2
P. stutzeri ATCC 17591
(reference strain)
genomovar 2
P. stutzeri ATCC 17588
(type strain)
genomovar 1
D-Fructose PositiveFootnote Table 1-3 [a] Positive[a] PositiveFootnote Table 1-3 [b]
Ethanolamine Positive[b] Positive[b] Negative[b]
Mannose Negative[b] Negative[b] Negative[b]
Mannitol Positive[a] Positive[b] Positive[b]
n-Propanol Positive[b] Positive[b] Negative[b]
Propionate Negative[b] Negative[b] Positive[b]
Propylene glycol Positive[b] Positive[b] Negative[b]
Valerate Negative[b] Positive[b] Positive[b]
Glycine Positive[a] Positive[a] Positive[a]
Ethylene glycol Positive[b] Positive[b] Negative[b]
Table 1-4 Molecular properties of P. stutzeri
Characteristic P. stutzeri ATCC 17587
(DSL strain)
genomovar 2
P. stutzeri ATCC 17591
(reference strain)
genomovar 2
P. stutzeri ATCC 17588
(type strain)
genomovar 1
G+C content (%) ~60.6% (Xiang et al., 2010) 61.4% (Rossello et al., 1991) 63.9% (Chen et al., 2011)
16S rRNA (GenBank Accession #) U25431 U26261 U26262

In addition to the properties summarized in the tables above, Health Canada also independently examined the growth on liquid media at different temperatures (Appendix A Table A-3), growth on different solid media at 37°C (Appendix A Table A-4) and fatty acid methyl-ester (FAME) profile (Appendix A Figures 3 and 4) of P. stutzeri ATCC 17587.

Analyses of the sequences of 16S rDNA or housekeeping genes complement phenotypic methods used to distinguish P. stutzeri from closely-related Pseudomonasspecies. A 16S rDNA consensus sequence was derived at Health Canada for P. stutzeri ATCC 17587 and was used as a query sequence against the DNA databases of the National Center for Biotechnology Information–Basic Local Alignment Search Tool (NCBI BLAST). Sequence alignment shows 99.86% rRNA homology to P. stutzeri type strain ATCC 17588 and 98% similarity to other Pseudomonas species, such as P. otitidis, P. pseudoalcaligenes, P. xanthomarina and P. putida.

Sequence differences in other markers and housekeeping genes have also been used to differentiate P. stutzeri from other Pseudomonas species. As shown in Figure 1, the relatedness of P. stutzeri to other validly described Pseudomonas species has been examined by comparingthe DNA gyrase B (gyrB) and the RNA polymerase sigma factor (rpoD)gene sequences (Yamamoto et al., 2000).

Figure 1-11: Schematic dendrogram summarizing the intrageneric structure of the genus Pseudomonas based on analysis of gyrB and rpoD sequences of 31 validly published species (Adapted from Yamamoto et al., 2000, with permission)

Figure 1-1 (See long description below)
Long description for Figure 1-1

Figure 1-1 shows a phylogenetic tree based on the analyses of the DNA gyrase B (gyrB) and the RNA polymerase sigma factor (rpoD) gene sequences of 31 Pseudomonas species. Roman numerals (I and II) indicate the two main intragenic clusters in the genus Pseudomonas. Cluster 1 comprises of the P. aeruginosa complex and the P. stutzeri complex. Cluster II contains the P. putida complex, the P. syringae complex and the P. fluorescens complex.

The resulting dendrogram (Figure 1-1) demonstrates the divergence of the genus Pseudomonas into two major intragenic clusters in which P. stutzeri belongs to the same cluster as P. aeruginosa. The PseudoMLSA Database is also used for multigenic sequence analysis of Pseudomonasspecies based on housekeeping genes, such as gyrB, rpoB and rpoD for P. stutzeri (Bennasar et al., 2010).

Housekeeping genes specifically targeting the denitrification pathway have been used to further differentiate P. stutzeri from closely-related species. These include the nosZ gene for nitrous oxide reductase (Zumft et al., 1990), the nirS gene for nitrite reductase, which is responsible for the reduction of nitrite (NO2−) to nitric oxide (NO) (Grüntzig et al., 2001), and the nifH gene for the nitrogenase enzyme (Chan et al., 1994).

Other phenotypic and molecular methods, such as the API 20NE commercial kit and Restriction Fragment Length Polymorphism (Bennasar et al., 1998), respectively, can also be used with other previously described techniques for the identification of P. stutzeri. Given the phenotypic and genotypic diversity of the P. stutzeri group, a polyphasic approach is important in generating a robust identification that allows for clear differentiation of P. stutzeri from closely-related pathogenic Pseudomonas species. None of the described techniques, however, can unequivocally differentiate the DSL-listed strain from other P. stutzeri strains.

1.2 Biological and ecological properties

The diversity of P. stutzeri is demonstrated by its adaptive ability to occupy a variety of ecological niches. P. stutzeri has been isolated from marine sediments and water column, deep-sea hydrothermal vents, wastewaters, sludge, garden soils, contaminated soils, plant roots and rhizosphere (reviewed in Lalucat et al., 2006; Bolognese at al., 1999), and as an intra-cellular symbiont with the dinoflagellate alga Alexandrium lusitanicum (Plumley et al., 1999). In a global study of denitrifying bacteria conducted by Gamble et al. (1997), P. stutzeri or stutzeri-like strains dominated the denitrifier population of approximately 106 CFU/g in soil and freshwater lake sediments at specific sites in Michigan, USA.

Long-term persistence of P. stutzeri ATCC 17587 in agricultural soil was investigated by Xiang et al. (2010). Using amplified fragment length polymorphism, quantitative PCR of the recovered P. stutzeri ATCC 17587 DNA from extracted soil was performed to estimate the cell concentration in the soil (Figure 1-2).

Figure 1-2: Persistence of Pstutzeri ATCC 17587 in soil based on qPCR analyses of extractable soil DNA (Adapted from Xiang et al., 2010, with permission)

Figure 1-2 (See long description below)
Long description for Figure 1-2

The line chart in Figure1-2 shows the persistence of P. stutzeri ATCC 17587 DNA in soil after 180 days. Following an initial decline in over 40 days, the cell concentration appears to reach equilibrium at a concentration of approximately log 7 cfu/g dry soil. P. stutzeri ATCC 17587 DNA is shown to persist in soil for at least 180 days.

As shown in Figure 1-2, DNA from P. stutzeri ATCC 17587 could be amplified from laboratory microcosms for at least 180 days after 108 to 1010 CFU/g were introduced (Xiang et al., 2010). Following an initial decline in recovered DNA over 40 days, the cell concentration appears to reach equilibrium at a concentration of approximately 107 CFU/g dry soil. This indicates that P. stutzeri ATCC 17587 is able to establish a niche and persist directly within the microcosm.

1.2.1 Growth conditions

Given the diversity of habitats where it is found, P. stutzeri is adaptable to a wide range of environmental conditions. Different strains of the species have different growth temperature ranges, overall spanning 4°C to 40°C (Palleroni, 2005), but growth at extremes of the temperature range is limited to selected strains (reviewed in Lalucat et al., 2006). P. stutzeri ATCC 17587 does not grow at 4°C and grows well at 40°C (Palleroni et al., 1970). Most strains of the species are unable to grow at pH 4.5 (reviewed in Lalucat et al., 2006). Growth kinetics (conducted at Health Canada) in various growth media at different temperatures are shown in Appendix A Tables A-3 and A-4.

Ude et al. (2006) observed that P. stutzeriATCC 17587 formed biofilms in vitro within 15 days of inoculation on King’s B medium at 20–22°C. Other P. stutzeri strains have been isolated from biofilms growing on copper and galvanized steel, which are commonly used in water-based heating and cooling systems (Dogruöz et al., 2009) and on dental unit water systems (Singh et al., 2003).

1.2.2 Nutrient cycling

P. stutzeri is active in nutrient cycling in the environment. It is well known for its simultaneous capacity for denitrification and nitrogen fixation, which are of relevance to the overall nitrogen cycling in several ecosystems (reviewed in Lalucat et al., 2006; Krotzky and Werner, 1987). Denitrification is a stable trait for P. stutzeri; it is one of the most active denitrifying, heterotrophic bacteria. The bacterial process of denitrification is normally a facultative trait. It provides bacteria with a respiratory pathway for anaerobic life (reviewed in Lalucat et al., 2006). Under anaerobic conditions, P. stutzeri denitrification is highly dependent on the presence of nitrate and nitrous oxide as electron acceptors (Korner and Zumft, 1989). Aerobic denitrification can only take place in P. stutzeri at low dissolved oxygen concentration (Körner and Zumft, 1989).

P. stutzeri may also play an important role in the turnover of thiosulfate in marine environments (Sorokin et al., 1999). P. stutzeri isolated from Baltic Sea sediments at the shoreline and in anoxic water column was found to oxidize thiosulfate to tetrathionate (40–50% of the thiosulfate sulfur) as the major product and to elemental sulfur (15–30%) (Podgorsek and Imhoff, 1999).

A P. stutzeri strain that is related to P. stutzeri strain DSM 50227 (a clinical isolate) contains the htx gene, which encodes for hypophosphite-2-oxoglutarate dioxygenase (White and Metcalf, 2004). This enzyme allows the organism to utilize phosphonates as an alternative source of phosphorus in low phosphate environments (Dyhrman et al., 2006).

Finally, some P. stutzeri strains, such as JM300 and CMT.9.A, have hydrogenase activity which supplies additional energy for metabolism (reviewed in Lalucat et al., 2006; Barraquio et al., 1988).

1.2.3 Plant growth promotion and biocontrol

P. stutzeri is present in the plant rhizosphere. For instance, P. stutzeri A15 and CMT.9.A have been isolated from the rhizosphere of rice in China (Rediers et al., 2003) and from the roots of a cultivar of Sorghum nutans (Yellow Indian Grass) in Germany (Krotzy and Werner, 1987). P. stutzeri strain A1501 has properties that facilitate its colonization and interaction with plants such as: motility, presence of global regulators, and nutritional and stress adaptation (reviewed in Hardoim et al., 2008). Genes promoting plant growth and preventing ethylene formation, which is an inhibitor of root elongation, were also identified in P. stutzeri A1501 (reviewed in García-Valdés et al., 2010). Also, P. stutzeri strain RP1, isolated from sunflower endorhizosphere, showed multiple plant growth-promoting attributes such as phosphate solubilization, auxin (indole-3-acetic acid), NH3 and HCN production, and antibacterial activity (Pandey et al., 2013). A P. stutzeri strain isolated from cyanobacteria-deprived lichens was able to release amino acids and 3-indoleacetic acid through the production of phytohormones, directly contributing to the nutrition of those lichens by releasing amino acids available to them, but was not able to solubilize phosphates (Liba et al., 2006).

Certain strains have been reported to have anti-algal, antibacterial and antifungal properties. P. stutzeri YPL-1 produces lytic extracellular enzymes which inhibit mycelial growth rather than spore germination and also causes lysis of Fusarium solani mycelia and germ tubes (Lim et al., 1991). Pandey et al. (2013) indicated that certain P. stutzeri strains showed antibacterial activity against Escherichia coli, Xanthomonas sp, Serratia marcescens and Bacillus cereus. Some P. stutzeri strains can also produce nocardamine (Meyer and Abdallah, 1980), which is an antibiotic covalently linked to a siderophore (Braun et al., 2009). This compound has antibacterial activity against certain mycobacteria (Wencewicz et al., 2013).

Three P. stutzeri strains, A41, B47 and MM4, that were isolated from sea sediment and aeration tanks of a sewage plant showed lethal activity against the red tide phytoplankton Chattonella antiqua, which lost its mobility and lysed. Moreover, the three strains did not show any toxicity on killifish (Cyprinodontidae family), which implies that they could be applied for the protection of cultivated fishes from the damage caused by red tide plankton (Hayashida et al., 1991).

1.2.4 Biosorption of metals and degradation of organic compounds

P. stutzeri has the potential to be used in biosorption of certain metals. For example, P. stutzeri strain KCCM 34719 demonstrated sorptive capacities (qmax) of 47.86 and 33.16 for cadmium(II) and copper(II), respectively. The optimum pH for biosorption rates is pH 5; above this value, the metals have been found to precipitate (Hassan et al., 2009).

P. stutzeri is metabolically diverse and is capable of degrading a range of organic substrates. Some P. stutzeristrains are able to metabolize aromatic hydrocarbons including mono- and di-halogen benzoates, benzenesulfonate, carbazole, cresol, dibenzothiophene, fluoranthene, fluorene, indan, naphthalene (Velayutham et al., 2012), polychlorinated biphenyls, phenanthrene, phenols, pyrene, quinoline, salicylate, tetralin, toluate, toluene, and xylene (reviewed in Lalucat et al., 2006).

P. stutzeriis also capable of degrading aliphatic hydrocarbons. For example, P. stutzeri strain KC, isolated from groundwater aquifer solids, is capable of transforming carbon tetrachloride to carbon dioxide under anoxic iron-limited condition (45–55% of carbon as determined by 14C labelling), to a non-volatile fraction (45–55% of carbon), and a cell-associated fraction (5% of carbon) (Criddle et al., 1990; Dybas et al., 1995). Strain JJ, isolated from soil contaminated with1,2-dichloroethane, oxidizes 2-chloroethanol (as sole energy and carbon source) completely to CO2 with NO3- or O2 as electron acceptor (Dijk et al., 2003).

Certain P. stutzeri strains have been found to degrade biocides, such as tributyltin, β-cyfluthrin, cyanide and thiocyanates, all of which are used in industrial and agricultural applications (reviewed in Lalucat et al., 2006).

1.2.5 Resistance to metals and chemical agents

Several naturally-occurring strains of P. stutzeri are resistant to metals such as aluminum, chromium, cobalt, copper, germanium, lead, manganese, nickel, plutonium, selenium, silver, thallium, titanium, uranium, vanadium and zinc (review by Lalucat et al., 2006). P. stutzeri is susceptible to a variety of chemical agents or biocides. For instance, a study comparing the effect of cationic antiseptics, mercury compounds, the parabens, phenolics and EDTA on six strains of P. stutzeri (NCIMB 568, 10783, 11358, 11359, JM 302, JM 375) has shown that all strains were found to be highly sensitive to chlorhexidine diacetate (CHA), organomercurials and triclosan, but less sensitive to quaternary ammonium compounds (Tattawasart et al., 1999); however, certain strains of P. stutzeri developed stable resistance to CHA or cetylpyridinium chloride (CPC) when exposed to gradually increasing concentrations of either antibacterial agent. Alterations in the cell envelope are likely to be responsible for non-specific changes in sensitivity to several antibacterial agents (Tattawasart et al., 1999). Resistance to CHA is likely linked to changes in the binding site(s) available at the outer membrane of the bacterium (Tattawasart et al., 2000).

1.2.6 Horizontal gene transfer

P. stutzeri is noted for its ability to become naturally competent for transformation (Sikorski et al., 2002) and can take up intraspecies and foreign DNA. Competence in P. stutzeri is a transient physiologic state that manifests at the transition between the log phase and stationary phase (reviewed in Lalucat et al., 2006).

Intraspecific DNA transformation through homologous recombination has been reported for P. stutzeriATCC 17587. Lorenz and Sikorski (2000) have shown that ATCC 17587 is highly transformable at a frequency of 2.6 ± 0.6 × 10−4 when grown on LB agar in the presence of DNA extracted from P. stutzeri rifampicin-resistant mutants. Although possible within the P. stutzeripopulation, Rius et al. (2001) reported that recombination is rare or absent between distinct P. stutzeri populations based on a multilocus enzyme electrophoresis analysis of 42 P. stutzeri strains belonging to several genomovars and isolated from different sources. Transformation of P. stutzeri ATCC 17587 with DNA from relatives within the same genus, Pseudomonas mendocina ATCC 25411 or P. alcaligenes ATCC 14909, was nearly two orders of magnitude lower than in intraspecific transformation (Lorenz and Sikorski, 2000). The frequency of foreign DNA acquisition events was only 0.0003% of the value observed for fully homologous DNA transformation (Lalucat et al., 2006).

In P. stutzeri, natural transformation requires the formation of functional type IV pili that affects the translocation of DNA into the cytoplasm (Graupner and Wackernagel, 2000; Graupner and Wackernagel, 2001). Transformation is also tightly controlled by comA gene which encodes for a competence transcription factor (Graupner and Wackernagel, 2001).

Conjugation and transduction in P. stutzeri also exist, but have not been studied in detail (reviewed in Lalucat et al., 2006). Transposons have been linked to the evolution and construction of catabolic pathways for degradation of organic contaminants in P. stutzeri (reviewed in Garcia-Valdes et al., 2010), while class 1 integrons have been associated with the dissemination of antibiotic resistance (Poirel et al., 2010) and the capture of metabolic islands (Garcia-Valdes et al., 2010). The genome of P. stutzeri ATCC 17587 has not been fully sequenced, so its complement of mobile genetic elements remains uncharacterized; however, Tetu and Holmes (2008) reported that P. stutzeri strain ATCC 17587 contains four copies of insertion sequence ISPst6. Several mobile genetic elements have been detected in other strains of P. stutzeri (Refer to Appendix B). Of particular importance is the presence of a class 1 integron in well-studied P. stutzeri species (The Uniprot Consortium, 2013; Winsor et al., 2011). The integron contains the blaIMP-16 gene which encodes imipenemase-type metallo-beta-lactamases that catalyze the hydrolysis of a broad range of beta-lactams, including carbapenem (Lee et al., 2004; Carvalho-Assef et al., 2010; Yan et al., 2001).

Transformation frequency of DNA within a P. stutzeripopulation could contribute to the genomic plasticity and diversity of the species (Ginard et al., 1997; Sikorski et al., 1999), which enable it to adapt to new ecological niches and to act as a reservoir of antibiotic resistance genes under long-term selective pressure in the hospital environment (Yan et al., 2001; Carvalho-Assef et al., 2010).

Compared to other P. stutzeri strains, P. stutzeri ATCC 17587 has a low transformation frequency (Lorenz and Sikorski, 2000). The possibility of P. stutzeri ATCC 17587 acquiring virulence genes from other species in the environment is considered limited.

1.3 Effects

1.3.1 Environment

An in-depth scientific literature search on P. stutzeri yielded only a few cases of naturally-occurring toxicity, virulence factors and pathogenicity towards plants and animals, despite the widespread presence of this species in the environment. In addition, the genomic study of P. stutzeri strain A1501 provided evidence of the absence of virulence genes that are found in P. aeruginosa PAO1, which is an opportunistic plant and animal pathogen. P. stutzeri does not carry genes for type III/VI secretion systems, the synthesis of both types of quorum-sensing molecules, alginate polymer synthesis, siderophores or antibiotic biosynthesis pathways (Yan et al., 2008).

Plants

A study looking at anti-algal bacteria reported that three strains of P. stutzeri showed lethal activity (i.e., lost motility and lysis) against a marine alga, Chattonella antiqua, which is known to cause red tide leading to serious damage to the commercial cultivation of yellowtails (fish) (Hayashida et al., 1991). The P. stutzeri anti-algal activity reaches its maximum after two to six days of cultivation with a lowest lethal concentration of 0.5% (w/v). In addition, no toxicity was observed, over the course of one week, towards co-cultured fish belonging to the Cyprinodontidae family (killifish) when fed a homogenized sardine meat supplemented with anti-algal bacteria P. stutzeri A41 (one loopful of bacteria per 5g of sardines). The selective toxicity of P. stutzeri implies that it could be applied for the protection of cultivated fishes from the damage caused by red tide plankton. No other pathogenicity information on aquatic plant species was found in the literature.

In terrestrial plant testing at Environment CanadaFootnote[2], red clover (Trifolium pratense) was grown in clay loam soil inoculated at day 0 with 108 CFU, at day 14 with 109 CFU and at day 28 with 109 CFU of P. stutzeri ATCC 17587 per gram of dry soil. A 21% decrease in root length was observed at the end of the study (day 42) for both the non-infectious control and the infectious treatment when compared with the negative control, which indicates that this effect may not be directly attributable to the live P. stutzeri ATCC 17587. A significant increase in shoot dry weight was observed in the non-infectious control and the infectious treatment, with no significant difference in root dry weight, regardless of treatment. Given the information above and the lack of a reduction in root dry weight, it is difficult to ascertain whether exposure to the bacteria, at these test concentrations, resulted in any adverse effect to red clover.

Invertebrates

Environment Canada also conducted research on the pathogenicity and toxicity of P. stutzeri ATCC 17587 on a soil arthropod. Folsomia candida (springtail, a soil invertebrate)was grown for 28 days in clay loam soil inoculated at day 0 with 108 CFU and at day 14 with 109 CFU of P. stutzeri ATCC 17587 per gram of dry soil. There was a significant decrease (14%) in adult survival in the infectious treatment when compared with both the negative control and non-infectious control, indicating pathogenicity to the invertebrate. There was also a decrease in juvenile production (45%) which may be attributable to a component of the bacterial cells which is still active once the cells are dead, as the difference in the effect between the live and killed cells was not statistically different.

P. stutzeri was used as a control in a study involving other pathogenic bacteria towards the nematode Caenorhabditis elegans. No effects were observed in the nematodes after 24 h exposure to 20 µL of viable P. stutzeri that wascultured on Luria broth and incubated at 37°C overnight (Balaji et al., 2004).

No reports in the literature have been found regarding pathogenicity of P. stutzeri towards aquatic invertebrates despite having been isolated from marine sediments and water column (reviewed in Lalucat et al., 2006).

Vertebrates

Fifteen different bacterial species were isolated from the respiratory tracts of various types of sick chickens suffering from a long-lasting syndrome or from the bone marrow of dead chickens. P. stutzeri was identified among these bacteria. To determine the etiological agent of infection, each bacterium was inoculated intraperitoneally (1 mL per chicken of 1010CFU/mL) into ten healthy four-week-old chickens. The isolate identified as P. stutzeri killed 20% of animals by one week post-inoculation, compared with 58% mortality observed with an isolate identified as P. aeruginosa. Drugs that successfully treated the P. stutzeri infection in chickens were apramycin, gentamicin, spectinomycin, oxytetracycline and sulfachloropyrazine (Lin et al., 1993). Another study reported the isolation of P. stutzeri from the conjunctiva of a captive Kori bustard (bird native to Africa) suffering from conjunctivitis. However, the occurrence of this isolation was very low (of the 537 diseased bustards examined, 32 had conjunctivitis and only one of them contained P. stutzeri) and the micro-organism was not confirmed to be the causative agent (Silvanose et al., 2001). No other information on pathogenicity to avian species was found in the literature.

Studies conducted at Health Canada showed no adverse effects following endotracheal administration of 106 CFU P. stutzeri ATCC 17587 in mice. No reports in the literature have been found regarding pathogenicity of P. stutzeri towards mammals, particularly towards grazing mammals despite the close association of P. stutzeri with plant roots (Rediers et al., 2003; Krotzy and Werner, 1987).

No reports in the literature have been found regarding pathogenicity of P. stutzeri towards fish or other aquatic vertebrates despite its isolation from marine sediments and water column (reviewed in Lalucat et al., 2006).

1.3.2 Humans

P. stutzeri is generally not considered as an etiological agent of infection in humans, but it is occasionally isolated from clinical samples. The speciesaccounts for only 1 to 2% of all Pseudomonas clinicalisolates (Noble and Overman, 1994; Bisharat et al., 2012). Most frequently, the clinical isolates were recovered from wounds, pus, blood, urine, tracheal aspirates and sputum (Holmes, 1986; Ergin and Mutlu, 1999; Noble and Overman, 1994; Bisharat et al., 2012).Noble and Overman (1994) reported that in most cases, P. stutzeri is not found as a single isolate but as part of a polymicrobial infection. The majority of P. stutzeri clinical isolates were reported to belong to genomovar 1 (Garcia-Valdes et al., 2010). This was supported by a recent study of 229 P. stutzeri strains from various origins.Scotta et al. (2013) reported that 136 of these strains were of clinical origin in which 88% belong to genomovar 1 and only 10% belong to genomovar 2 (including ATCC 17587).

P. stutzeri has been intermittently linked to secondary infections in patients with existing health conditions or who have undergone invasive medical procedures. These include pneumonia (Campos-Herrero, 1997; Carratala et al., 1992; Loyse et al., 2006; Potvliege et al., 1987), septicemia (Bello, 2007; Potvliege et al., 1987; Priestly et al., 1996), arthritis (Bishara et al., 2000; Miron et al., 2007), conjunctivitis (Singh, 2008), endocarditis (Grimaldi et al., 2009; Rosenberg et al., 1987), panophthalmitis (Lebowitz et al., 2001) and meningitis (Chang et al., 1996; Roig et al., 1996).

Hospital-acquired P. stutzeri infections, such as endopthalmitis (Jiraskova and Rozsival, 1998), brain abscess (Yee-Guardino et al., 2006) and peritonitis (Ceri et al., 2010) have also been reported. Rare infections in otherwise healthy individuals include an isolated case of pneumonia and empyema (Kose et al., 2004) and osteomyelitis (Reisler and Blumberg, 1999; Rowley et al., 1987) in children.

Very few outbreaks related to P. stutzeri were reported, all of which occurred during the 1970s and 1980s. These include bacteremia, septicaemia and peritonitis that were attributed to contamination of intravenous fluids (Felts et al., 1972), catheters (Elting et al., 1990), a water system used for hemodialysis (Goetz et al., 1983), or soap used to prepare the skin for intravenous insertions (Keys et al., 1983). No other outbreaks of P. stutzeri infection have since been reported in the scientific literature. P. stutzeri infections have rarely resulted in mortality. Deaths are often directly attributed to significant comorbidities, rather than to the presence of P. stutzeri in the clinical material (Bisharat et al., 2012).

While generally resistant to cephalosporins, monobactams and macrolides, P. stutzeri infections have been successfully treated with a wide range of antibiotics, including aminoglycosides, fluoroquinolones, carbapenems, antipseudomonal penicillins, and trimethoprim-sulfamethoxazole (reviewed in Lalucat et al., 2006; Noble and Overman, 1994). Antibiotic susceptibility patterns of 93 P. stutzeri isolated from clinical specimens during a 10-year period (2000–2010) were reviewed by Bisharat et al. (2012) and are consistent with prior studies showing that P. stutzeri is susceptible to many antibiotics. Excluding ceftazidime, third- and fourth–generation cephalosporins are not optimal therapies for P. stutzeriinfections with a coverage rate ranging from 50–70% (Bisharat et al., 2012). Antibiotic susceptibility testing conducted by Health Canada in 2011 indicates that P. stutzeri ATCC 17587 is susceptible to ciprofloxacin (fluoroquinolone), meropenem (carbapenem), gentamicin (aminoglycoside) and ceftazidime (cephalosphorin), and is tolerant to cefotaxime (cephalosporin), which are consistent with the findings in the literature for clinical isolates of P. stutzeri.

Resistance to monobactams could be attributed to the presence of IMP- and VIM-type metallo-beta-lactamases in the chromosome (Yan et al., 2001; Lee et al., 2004; Carvalho-Assef et al., 2010), while resistance to macrolides could be due to alterations of the outer membrane proteins and LPS (Tattawasart et al., 2000).

In vitro and in vivo tests conducted at Health Canada found no evidence of cytotoxic effects on human colonic epithelial cells (HT29) after 6, 12 or 24 h of exposure to P. stutzeri strain ATCC 17587.

P. stutzeri strain ATCC 17587, and no haemolytic activity was observed on sheep blood agar after 24 h or 48 h at 37°C. In four BALB/c mice exposed to 1.0 × 106CFU/25 μL by endotracheal instillation, no changes in behaviour or physical appearance were observed and the animals were asymptomatic. No significant increase in lung granulocytes over the one week sampling period and no increase in lung or blood cytokine marker levels were detected one week after exposure. All bacteria were cleared by 96 h after exposure from lungs, trachea and esophagus, and the organs remained clear at 7 days.

P. stutzeri has relatively low virulence compared to the virulent species of Pseudomonas and Burkholderia, presumably due to the absence of virulence factors in P. stutzeri (Yan et al., 2008). A search of the literature and of the Pseudomonas Genome Database for five fully sequenced P. stutzeri strains (A1501, ATCC 17588, CCUG 29243, DSM 10701 and DSM 4166) confirms the absence of the following virulence factors that play an important role in the adherence, invasion, evasion of host defences, biofilm formation, and damage to host cells:

P. stutzeri has been associated with a toxin produced by red tide algae that has been linked to paralytic shellfish poisoning (Plumley et al., 1999; Martins et al., 2003). However, further investigation showed that P. stutzeri does not produce this toxin, but under certain growth conditions, has the potential to sequester the algal toxins in its cell wall (Baker et al., 2003; Martins et al., 2003). No toxin production by P. stutzeri has been reported in the literature.

No cases of allergic reaction have been reported specifically on P. stutzeri strain ATCC 17587; however other strains of P. stutzeri have been isolated along with other organisms from metal-working fluids that cause hypersensitivity pneumonitis at metalworking plants (Gilbert et al, 2010; Bracker et al., 2003). Like all micro-organisms, P. stutzeri contains or produces components, such as lipopolysaccharides and enzymes, that may act as immune stimulants, allergens or sensitizers. Sensitization or allergic reactions to micro-organisms could occur via dermal and respiratory routes in frequently exposed or susceptible individuals (Martel et al., 2010; Ring et al., 1992).

1.4 Hazard severity

P. stutzeri is a well-defined microbial species. A combination of morphological, biochemical, and physiological traits allow it to be reliably discriminated from other Pseudomonas species, especially closely-related pathogens such as P. aeruginosa. Despite the widespread presence of P. stutzeri in soil and water and in close association with plant roots, only one isolate has been reported to be pathogenic towards chickens, which were successfully treated with antibiotics. Certain strains of P. stutzeri have anti-algal, antibacterial and antifungal properties. As previously mentioned in Section 1.3.1, experimental challenges with P. stutzeri ATCC 17587 on springtails revealed a significant decrease in adult survival and juvenile production at concentrations which can be reached during bioremediation uses (Dybas et al., 2002; Silva et al., 2004). However, there is no evidence that P. stutzeri ATCC 17587 has adversely affected terrestrial invertebrates at the population level in spite of widespread distribution of P. stutzeri in the environment. Thus, the environmental hazard severityfor P. stutzeri ATCC 17587 is estimated to be low.

No human infections have been specifically attributed to the DSL strain P. stutzeri ATCC 17587 in the scientific literature. Nonetheless, there have been a few reports of secondary infection from other P. stutzeri isolates in individuals with predisposing factors such as compromised immunity, trauma, previous surgery or invasive medical procedures, or are hospital acquired. While most of the recovered P. stutzericlinical isolates belong to genomovar 1, a few strains belonging to genomovar 2 have been identified (including ATCC 17587). The human hazard severityfor P. stutzeri ATCC 17587 is therefore estimated to be low-medium.

Hazards related to micro-organisms used in the workplace should be classified accordingly under the Workplace Hazardous Materials Information System (WHMIS)Footnote[3].

Top of Page

2. Exposure Assessment

An exposure assessment identifies the mechanisms by which a micro-organism is introduced into a receiving environment (Section 2.1) and qualitatively and/or quantitatively estimates the magnitude, likelihood, frequency, duration, and/or extent of human and environmental exposure (Section 2.2). Exposure to the micro-organism itself, its genetic material, toxins, metabolites and structural components is assessed in this section.

2.1 Sources of exposure

As a species, P. stutzeri is naturally present in the environment. The purpose of this assessment is to characterize the exposure to P. stutzeri ATCC 17587 from its deliberate addition to consumer or commercial products or its use in industrial processes.

P. stutzeri ATCC 17587 was nominated to the DSL in 2005 because it was manufactured in or imported into Canada between January 1, 1984, and December 31, 1986, and it entered or was released into the environment without being subject to conditions under CEPA 1999 or any other federal or provincial legislation.

Responses to a 2007 voluntary questionnaire sent to a subset of key biotechnology companies in Canada, combined with information obtained from other federal government regulatory and non-regulatory programs, indicate that a very small amount of P. stutzeri ATCC 17587 was imported into Canada for research and development in the 2006 reporting year.

The Government conducted a mandatory information-gathering survey under section 71 of CEPA 1999 (referred to as the section 71 Notice), as published in the Canada Gazette, Part I, on October 3, 2009. The section 71 Notice applied to any persons who, during the 2008 calendar year, manufactured or imported P. stutzeri ATCC 17587, whether alone, in a mixture, or in a product. No commercial or consumer activities using P. stutzeri ATCC 17587 were reported in response to the section 71 Notice.

P. stutzeri is metabolically diverse which could make it of commercial interest in a variety of industries, particularly in water treatment and degradation of xenobiotic compounds. A search of the public domain yielded the following ongoing consumer, commercial and industrial applications of other naturally-occurring strains of P. stutzeri:

Some potential uses of other naturally-occurring P. stutzeri identified from patent submissions include:

2.2 Exposure characterization

2.2.1 Environment

The environmental exposure for P. stutzeri ATCC 17587 is estimated to be low based on the absence of responses to the Section 71 Notice, suggesting that this strain is no longer used in consumer or commercial products or for industrial processes in Canada.

Nevertheless, environmental exposure scenarios, in the event that consumer, commercial or industrial activities with P. stutzeri ATCC 17587 resume, have been considered along with persistence and survival properties of this micro-organism.

The magnitude of plant and animal exposure to the P. stutzeri ATCC 17587 will depend on its persistence and survival in the environment. P. stutzeri does not form spores, so it cannot survive for long periods without nutrients or resist extremes of temperature, radiation or chemicals (reviewed in Setlow, 2006). However, P. stutzeri is metabolically versatile and is expected to readily colonize new terrestrial environments. Xiang et al. (2010) investigated the persistence of P. stutzeri ATCC 17587 in microcosm soil and reported that populations of this strain dominated, following an initial adaptation period after inoculation, and remained stable with a relatively high abundance of 107 CFU/g dry soil throughout the soil incubation experiment. In addition, naturally-occurring P. stutzeri strains have been isolated from various aquatic ecosystems. Lalucat et al. (2006) suggested that P. stutzeri is a true marine species because of its ability to tolerate high salt concentration. Marine strains of P. stutzeri are located in the water column and in sediments where they play a role in nitrogen cycling. Several strains have also been isolated from contaminated groundwater and wastewaters, thus confirming that P. stutzeri can survive in freshwater habitats (reviewed in Lalucat et al., 2006; Criddle et al., 1990; Dybas et al., 1995). Overall, P. stutzeri ATCC 17587 should be able to survive and persist in most terrestrial, aquatic and marine environments.

The following exposure scenarios are based on known uses of other strains and probable future uses as described in Section 2.1 Sources of exposure. Uses such as bioremediation, agricultural odour control, solid waste management, composting and disposal of solid wastes from industrial uses of the organism are likely to introduce P. stutzeri ATCC 17587 to terrestrial ecosystems. Terrestrial invertebrates living in the soils at the site of application or disposal and plants growing in treated soils are likely to be the most directly exposed. Vertebrates could ingest P. stutzeri ATCC 17587 while feeding on plants or invertebrates growing in treated or contaminated soils.

Aquatic and marine species may come into contact with P. stutzeri ATCC 17587 from runoff subsequent to terrestrial application and from the direct application of P. stutzeri ATCC 17587 to water bodies for uses such as water restoration (fresh and salt water), wastewater treatment, or disposal of wastewater from applications such as recovery of oil and metals or the manufacture of enzymes, detergents and food additives.

Aquatic applications could also expose terrestrial species. For example, grazing animals could ingest P. stutzeri ATCC 17587 subsequent to its use in water restoration in cattle dugouts, and plants and soil invertebrates could be exposed subsequent to the treatment of irrigation ponds.

In the event that consumer, commercial or industrial activities resume, the environmental exposure to P. stutzeri ATCC 17587 will likely increase. The environmental compartments and species that will be exposed to the DSL strain will depend on the uses outlined in the exposure scenarios described above.

2.2.2 Human

Based on the absence of consumer or commercial activity in Canada according to the Section 71 Notice, the overall human exposure estimation for P. stutzeri ATCC 17587 islow. Nevertheless, given the range and scale of known and potential applications of the species P. stutzeri listed in Section 2.1 Sources of exposure, there is potential for an increase in human exposure to products containing P. stutzeriATCC 17587, and exposure scenarios arising from these products have been considered.

Should products containing P. stutzeri ATCC 17587 become available in Canada, human exposure could be greatestthrough the use of consumer products intended for the treatment of aquariums and decorative ponds, degreasing of kitchen drains, cleaning and deodorizing of septic tanks, and composting. Handling and application of such products would be expected to result in direct exposure to the skin and through inhalation of aerosolized droplets or dusts containing P. stutzeri ATCC 17587 in the lungs.

Secondary to product application, residual P. stutzeriATCC 17587 on surfaces and in reservoirs such as treated drains could result in dermal exposure, exposure through inadvertent ingestion where the organism persists on food preparation surfaces, and inhalation where aerosols are generated (e.g., from kitchen garbage disposal units). Since P. stutzeri ATCC 17587 is expected to persist following application, such exposures may be temporally distant from the time of application.

Should commercial products containing P. stutzeriATCC 17587 become available in Canada, the general population could be exposed as bystanders during commercial product application. The extent of bystander exposure will depend on the mode of application, the volume applied, and the proximity of bystanders to the site of application, but in general is expected to be moderate.

Human exposure to bodies of water and soil treated with P. stutzeri ATCC 17587, (e.g., through recreational activities), could also result in exposure of the skin and eyes, as well as inadvertent ingestion, however dilution of the product is expected to significantly reduce exposure relative to household application scenarios.

Indirect exposure to P. stutzeri ATCC 17587 in the environment subsequent to its use in oil recovery, water and wastewater treatment, soil bioremediation, or disposal of waste from its use in the production of enzymes is also likely to occur in the vicinity of application or disposal sites, but is expected to be no greater than direct exposure from the use of the organism in consumer products.

In the event that the organism enters municipal drinking water treatment systems through release from potential uses, the water treatment process, which includes coagulation, flocculation, ozonation, filtration and chlorination, is expected to effectively eliminate these micro-organisms from drinking water.

In the event that the potential consumer, commercial or industrial uses of P. stutzeri ATCC 17587 are realized, human exposure through the exposure scenarios described above can be expected and could include direct, possibly repeated, exposure to concentrated preparations of P. stutzeriATCC 17587.

Top of Page

3. Risk Characterization

In this assessment, risk is characterized according to a paradigm embedded in section 64 of CEPA 1999 that a hazard and exposure to that hazard are both required for there to be a risk. The risk assessment conclusion is based on the hazard and on what is known about exposure from current uses.

Hazard has been estimated for P. stutzeri ATCC 17587 to be low for the environment and low-medium for human health. Environmental and human exposure to P. stutzeriATCC 17587 from its deliberate use in industrial processes or consumer or commercial products in Canada is not currently expected (low exposure), so the risk associated with current uses is estimated to be low for both the environment and human health. 

The determination of risk from current uses is followed by consideration of the estimated hazard in relation to foreseeable future exposures (from new uses). If a risk may be associated with new uses or activities, the government can take action through the application of the Significant New Activity provisions to require an assessment of these new uses or activities before they begin.

Nevertheless, P. stutzeri ATCC 17587 has useful properties that could result in environmental and human exposure to products containing this strain in the future. The risk from foreseeable potential uses of P. stutzeri ATCC 17587 remains low given that there is no evidence of effects to human health or of adverse ecological effects at the population level for environmental species in spite of widespread distribution of P. stutzeri in the environment and of history of industrial, environmental, and commercial uses.

In susceptible humans, P. stutzeri can act as an opportunistic pathogen. Compared with other closely-related opportunistic Pseudomonas pathogens, the incidence of nosocomial (hospital-acquired) or secondary infection due to P. stutzeri in individuals with compromised immunity and underlying medical conditions is low. Only three reports of P. stutzeri infection in otherwise healthy individuals were found in the literature. In the unlikely event of infection with P. stutzeri ATCC 17587 arising from its use in industrial processes, consumer or commercial products, a number of clinically-relevant antibiotics are effective against P. stutzeri ATCC 17587. The risk from foreseeable potential uses of P. stutzeri ATCC 17587 to the environment and general population and is expected to be low.

Top of Page

4. Conclusion

Based on responses to the section 71 Notice in 2009, it is concluded that P. stutzeri ATCC 17587 is not entering the environment in a quantity or concentration or under conditions that:

Therefore, it is concluded that this substance does not meet the criteria as set out in section 64 of the CEPA 1999.

Top of Page

5. References

Alsop, A.W., Anyzek, S., Fallon, R.D., Hendrickson, E.R., Keeler, S.J., and Perry, M.P. (2012). Prevention of biomass aggregation at injection wells. CIPO 28184400.

Baker, T.R., Doucette, G.J., Powell, C.L., Boyer, G.L., and Plumley, F.G. (2003). GTX4 imposters: characterization of fluorescent compounds synthesized by Pseudomonas stutzeriSF/PS and Pseudomonas/Alteromonas PTB-1, symbionts of saxitoxin-producing Alexandrium spp. Toxicon 41, 339–347.

Balaji, V., Jesudason, M.V., Sridharan, G., and Subramanian, K. (2004). Detection of virulence attributes of Burkholderia pseudomallei. Indian J. Med. Res. 119, 101–106.

Barraquio, W.L., Dumont, A., and Knowles, R. (1988). Enumeration of free-living aerobic N2-fixing H2-oxidizing bacteria by using a heterotrophic semisolid medium and most-probable- number technique.54, 1313–1317.

Bello, C.S.S. (2007). Pseudomonas stutzeri: A rare cause of neonatal septicaemia.13, 731–734.

Bennasar, A., Mulet, M., Lalucat, J., and García-Valdés, E. (2010). PseudoMLSA: a database for multigenic sequence analysis of Pseudomonas species. BMC Microbiol. 10,1–6.

Bhosle, N., and Giriyan, A. (2003). Novel "Pseudomonas stutzeri" strain and process for preparation of xylanase. US Patent 20030008379 A1.

Bishara, J., Robenshtok, E., Samra, Z., and Pitlik, S. (2000). Prosthetic knee septic arthritis due to Pseudomonas stutzeri. Can. J. Infect. Dis. 11, 329–331.

Bisharat, N., Gorlachev, T., and Keness, Y. (2012). 10-years hospital experience in Pseudomonas stutzeri and literature review. Open Infect. Dis. J. 6, 21–24.

Borg, C., Friese, D., and Tyze-Kuan, T.Y. (2012). Removal of selenium in contaminated wastewater streams. US Patent 8323497B2.

Bolognese, F., Di Lecce, C., Galli, E., and Barbieri, P. (1999). Activation and inactivation of Pseudomonas stutzerimethylbenzenecatabolism pathways mediated by a transposable element. Appl. Environ. Microbiol. 65, 1876–1882.

Bosch-Roig, P., Regidor-Ros, J.L., Soriano-Sancho, P., and Montes-Estellés, R.M. (2013). Biocleaning of animal glue on wall paintings by Pseudomonas stutzeri. Chim. Oggi 31,50–53.

Bracker, A., Storey, E., Yang, C., and Hodgson, M.J. (2003). An outbreak of hypersensitivity pneumonitis at a metalworking plant: A longitudinal assessment of intervention effectiveness. Appl. Occup. Environ. Hyg. 18, 96–108.

Braun, V., Pramanik, A., Gwinner, T., Köberle, M., and Bohn, E. (2009). Sideromycins: tools and antibiotics. Biometals. 22(1), 3–13.

Brierley, J.A., and Kulpa, C.F. (1993). Biometallurgical treatment of precious metal ores having refractory carbon content. US Patent 5244493 A.

Campos-Herrero, M., Bordes, A., Rodríguez, H., Perera, A., González, B., and Conde, A. (1997). Pseudomonas stutzericommunity-acquired pneumonia associated with empyema: Case report and review. Clin. Infect. Dis. 25, 325–326.

Carratala, J., Salazar, A., Mascaro, J., and Santin, M. (1992). Community-acquired pneumonia due to Pseudomonas stutzeri. Clin. Infect. Dis. 14, 792.

Carvalho-Assef, A., Gomes, M.Z.R., Silva, A.R.A., Werneck, L., Rodrigues, C.A.S., Souza, M.J., and Asensi, M.D. (2010). IMP-16 in Pseudomonas putida and Pseudomonas stutzeri: Potential reservoirs of multidrug resistance. J. Med. Microbiol. 59, 1130–1131.

Ceri, M., Ortabozkoyun, L., Altay, M., Unverdi, S., Kurultak, I., Huddam, B., Kilic, F., Yilmaz, R., and Duranay, M. (2010). Peritonitis due to Pseudomonas stutzeri, an organism that may be difficult to culture. Periton. Dialysis Int 30,484–486.

Chan, Y.-., Barraquio, W.L., and Knowles, R. (1994). N2-fixing pseudomonads and related soil bacteria. FEMS Microbiol. Rev. 13, 95–118.

Chang, H.J., Christenson, J.C., Pavia, A.T., Bobrin, B.D., Bland, L.A., Carson, L.A., Arduino, M.J., Verma, P., Aguero, S.M., Carroll, K., et al. (1996). Ochrobactrum anthropiMeningitis in Pediatric Pericardial Allograft Transplant Recipients. J. Infect. Dis. 173, 660.

Chen, M., Yan, Y., Zhang, W., Lu, W., Wang, J., Ping, S., and Lin, M. (2011). Complete genome sequence of the type strain Pseudomonas stutzeri CGMCC 1.1803. J. Bacteriol. 193, 6095.

Choban, E.R., Fallon, R.D., Hendrickson, E.R., Jackson, S.C., Luckring, A.K., Perry, M.P., Suchanec, D.A., and Anyzek, S. (2013). Altering the interface of hydrocarbon-coated surfaces. CIPO CA 2758325.

Cladera, A.M., Bennasar, A., Barceló, M., Lalucat, J., and García-Valdés, E. (2004). Comparative Genetic Diversity of Pseudomonas stutzeri Genomovars, Clonal Structure, and Phylogeny of the Species. J. Bacteriol. 186,5239–5248.

Criddle, C.S., DeWitt, J.T., Grbic-Galic, D., and McCarty, P.L. (1990). Transformation of carbon tetrachloride by Pseudomonas sp. strain KC under denitrification conditions. Appl. Environ. Microbiol. 56, 3240–3246.

Christie-Oleza, J.A., Lanfranconi, M.P., Nogales, B., Lalucat, J., and Bosch, R. (2008). Conjugative interaction induces transposition of ISPst9 in Pseudomonas stutzeri AN10. J Bacteriol. 191(4), 1239–1247.

Daimon, K., and UYama, N. (2001). Redeposition or backstain inhibition during stonewashing process. CIPO 2413838A1, US Patent 6797010 B2.

Diggle, S.P., Cornelis, P., Williams, P., and Cámara, M. (2006). 4-Quinolone signalling in Pseudomonas aeruginosa: Old molecules, new perspectives. Int. J. Med. Microbiol. 296, 83–91.

Dijk, J.A., Stams, A.J.M., Schraa, G., Ballerstedt, H., De Bont, J.A.M., and Gerritse, J. (2003). Anaerobic oxidation of 2-chloroethanol under denitrifying conditions by Pseudomonas stutzeri strain JJ. Appl. Microbiol. Biotechnol. 63,68–74.

Dogruöz, N., Göksay, D., Ilhan-Sungur, E., and Cotuk, A. (2009). Pioneer colonizer microorganisms in biofilm formation on galvanized steel in a simulated recirculating cooling-water system. J. Basic Microbiol. 49, S5–S12.

Durham, D.K., and Harless, M.L. (2012). Method for the use of nitrates and nitrate reducing bacteria in hydraulic fracturing. CIPO 2812167.

Dybas, M.J., Tatara, G.M., and Criddle, C.S. (1995). Localization and characterization of the carbon tetrachloride transformation activity of Pseudomonas sp. strain KC. Appl. Environ. Microbiol. 61, 758–762.

Dybas, M. J., Hyndman, D.W., Heine, R., Tiedje, J., Linning, K., Wiggert, D., Voice, T., Zhao, X., Dybas, L. and Criddle, C.S. (2002). Development, operation, and long-term performance of a full-scale biocurtain utilizing bioaugmentation. Environ. Sci., Technol. 36: 3635–3644.

Dyhrman, S.T., Chappell, P.D., Haley, S.T., Moffett, J.W., Orchard, E.D., Waterbury, J.B., and Webb, E.A. (2006). Phosphonate utilization by the globally important marine diazotroph Trichodesmium. Nature 439, 68–71.

Elting, L.S., and Bodey, G.P. (1990). Septicemia due to Xanthomonas Species and Non-Aeruginosa Pseduomonas Species: Increasing Incidence of Catheter-Related Infections. Medicine 69, 296–306.

Environment Canada and Health Canada. (2011). Framework on the Science-Based Risk Assessment of Micro-organisms under the Canadian Environmental Protection Act, 1999.http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=120842D5-1.

Environment Canada. (2004). Guidance Document for Testing the Pathogenicity and Toxicity of New Microbial Substances to Aquatic and Terrestrial Organisms. EPS1/RM/44. Method Development and Applications Section. Environmental Technology Centre. http://publications.gc.ca/collections/Collection/En49-7-1-44E.pdf (viewed October 2013).

Ergin, C., and Mutlu, G. (1999). Clinical distribution and antibiotic resistance of Pseudomonas species. East J Med 4, 65–69.

Fallon, R.D., Hendrickson, E.R., Jackson, S.C., Keeler, S.J., Luckring, A.K., and Rees, B.C. (2012). Methods, strains, and compositions useful for microbially enhanced oil recovery: Pseudomonas stutzeri. US Patent 20120277126 A1.

Farin, F., Labout, J.J.M., and Verschoor, G.J. (1993). Lipolytic enzymes and their use in detergent compositions. CIPO 1313360.

Felts, S.K., Schaffner, W., and Melly, A. (1972). Sepsis Caused by Contaminated Intravenous Fluids: Epidemiologic, Clinical, and Laboratory Investigation of an Outbreak in Once Hospital. Ann. Intern. Med. 77, 890.

Fialho, A.M., Zielinski, N.A., Fett, W.F., Chakrabarty, A.M., and Berry, A. (1990). Distribution of alginate gene sequences in the Pseudomonas rRNA homology group I-Azomonas-Azotobacter lineage of superfamily B prokaryotes. Appl. Environ. Microbiol. 56, 436–443.

FSANZ. (2010). Food and Standards Australia and New Zealand Approval Report. Application A1033 Maltotetraohydrolase as a processing aid (enzyme). http://www.foodstandards.gov.au/code/applications/documents/A1033%20Maltotetraohydrolase%20Appr%20FINAL.pdf (viewed June 2013).

Gamble, T.N., Betlach, M.R., and Tiedje, J.M. (1977). Numerically dominant denitrifying bacteria from world soils. Appl. Environ. Microbiol. 33, 926–939.

Garcia-Valdes, E., Mulet, M., and Lalucat, J. (2010). Chapter 6: Insights into the lifestyles of Pseudomonas stutzeri. In Pseudomonas. Volume 6 Molecular Microbiology, Infection and Biodiversity. Ramos, J. L., and Filloux, A. eds., (New York: Springer) pp. 177–198.

Ginard, M., Lalucat, J., Tümmler, B., and Römling, U. (1997). Genome organization of Pseudomonas stutzeri and resulting taxonomic and evolutionary considerations. Int. J. Syst. Bacteriol. 47, 132–143.

Goetz, A., Yu, V.L., Hanchett, J.E., and Rihs, J.D. (1983). Pseudomonas stutzeri Bacteremia Associated With Hemodialysis. Arch Intern Med 143, 1909–1912.

Graupner, S., and Wackernagel, W. (2000). A broad-host-range expression vector series including a Ptac test plasmid and its application in the expression of the dod gene of Serratia marcescens (coding for ribulose-5-phosphate 3-epimerase) in Pseudomonas stutzeri. Biomol. Eng. 17,11–16.

Graupner, S., and Wackernagel, W. (2001). Identification and characterization of novel competence genes comA and exbB involved in natural genetic transformation of Pseudomonas stutzeri. Res. Microbiol. 152, 451–460.

Grimaldi, D., Podglajen, I., Aubert, A., Buu-Hoï, A., Diebold, B., and Mainardi, J. (2009). Case of indolent endocarditis due to Pseudomonas stutzeri with genetic evidence of relapse after 4 years. J. Clin. Microbiol. 47, 503–504.

Grüntzig, V., Nold, S.C., Zhou, J., and Tiedje, J.M. (2001). Pseudomonas stutzeri nitrite reductase gene abundance in environmental samples measured by real-time PCR. Appl. Environ. Microbiol. 67, 760–768.

Hardoim, P.R., van Overbeek, L.S., and Elsas, J.D.v. (2008). Properties of bacterial endophytes and their proposed role in plant growth. Trends Microbiol. 16, 463–471.

Hayashida, S., Tanaka, S., Teramoto, Y., Nanri, N., Yoshino, S., and Furukawa, K. (1991). Isolation of Anti-Algal Pseudomonas stutzeri Strains and Their Lethal Activity for Chattonella antiqua.. Agric. Biol. Chem. 55(3), 787–790.

Henderson, L., and Higgins, D. (2007). Processes for making ethanol. US Patent 20070190627A1.

Holmes, B. (1986). Identification and distribution of Pseudomonas stutzeri in clinical material. J. Appl. Bacteriol. 60, 401–411.

Insell, J.P. (1992). Microbial catabolism of tertiary butyl alcohol. CIPO 1304031.

Jiraskova, N., and Rozsival, P. (1998). Delayed-onset Pseudomonas stutzeri endophthalmitis after uncomplicated cataract surgery. J. Cataract Refract. Surg. 24,866–867.

Keeler, S.J., Fallon, R.D., Hendrickson, E.R., Hnatow, L.L., Jackson, S.C., and Perry, M.P. (2013). Identification, characterization, and application of Pseudomonas stutzeri (LH4:15), useful in microbially enhanced oil release. US Patent 8357526 B2; CIPO 2717852A1.

Keys, T.F., Melton III, L.J., Maker, M.D., and Ilstrup, D.M. (1983). A suspected hospital outbreak of pseudobacteremia due to Pseudomonas stutzeri. J. Infect. Dis. 147,489–493.

Kitahara, M., Ishii, K., Kawaharada, H., and Watanabe, K. (1989). 7-hydroxyguanine compounds, process for preparing said compounds, and anti-tumor agent contaning the same. CIPO 1263946.

Korner, H., and Zumft, W.G. (1989). Expression of denitrification enzymes in response to the dissolved oxygen levels and respiratory substrate in continuous culture of Pseudomonas stutzeri. Appl. Environ. Microbiol. 55,1670–1676.

Köse, M., Öztürk, M., Kuyucu, T., Güneþ, T., Akçakuþ, M., and Sümerkan, B. (2004). Community-acquired pneumonia and empyema caused by Pseudomonas stutzeri: A case report. Turk. J. Pediatr. 46, 177–178.

Kragh, K.M., and Sorensen, B.S. (2005). Food additive comprising Pseudomonas non-maltogenic exoamylase variants. CIPO 2531647, WO/2005/003339.

Krotzky, A., and Werner, D. (1987). Nitrogen fixation in Pseudomonas stutzeri. Arch. Microbiol. 147,48–57.

Lalucat, J., Bennasar, A., Bosch, R., García-Valdés, E., and Palleroni, N.J. (2006). Biology of Pseudomonas stutzeri. Microbiol. Mol. Biol. Rev. 70, 510–547.

Lebowitz, D., Gürses-Özden, R., Rothman, R.F., Liebmann, J.M., Tello, C., and Ritch, R. (2001). Late-Onset Bleb-Related Panophthalmitis With Orbital Abscess Caused by Pseudomonas stutzeri. Arch. Ophthalmol. 119, 1723–1725.

Lee, V.K., and Levy, E.M. (2005). Enhanced biodegradation of a light crude oil in sandy beaches. Paper presented at 2005 International Oil Spill Conference. Miami Beach, Florida. 2449.

Lee, N.Y., Yan, J.J., Lee, H.C., Liu, K.H., Huang, S.T., and Ko, W.C. (2004). Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms. J. Microbiol. Immunol. Infect. 37, 343–349.

Leung, K., Trevors, J.T., and Lee, H. (1995). Survival of and lacZ expression recombinant Pseudomonas strains introduced into river water microcosms. Can. J. Microbiol. 41,461–469.

Liba, C.M., Ferrara, F.I.S., Manfio, G.P., Fantinatti-Garboggini, F., Albuquerque, R.C., Pavan, C., Ramos, P.L., Moreira-Filho, C.A., and Barbosa, H.R. (2006). Nitrogen-fixing chemo-organotrophic bacteria isolated from cyanobacteria-deprived lichens and their ability to solubilize phosphate and to release amino acids and phytohormones. J. Appl. Microbiol. 101, 1076–1086.

Lim, H.-., Kim, Y.-., and Kim, S.-. (1991). Pseudomonas stutzeri YPL-1 genetic transformation and antifungal mechanism against Fusarium solani, an agent of plant root rot. Appl. Environ. Microbiol. 57, 510–516.

Lin, M.Y., Cheng, M.C., Huang, K.J., and Tsai, W.C. (1993). Classification, pathogenicity, and drug susceptibility of hemolytic gram-negative bacteria isolated from sick or dead chickens. Avian Dis. 37, 6–9.

Lorenz, M.G., and Sikorski, J. (2000). The potential for intraspecific horizontal gene exchange by natural genetic transformation: Sexual isolation among genomovars of Pseudomonas stutzeri. Microbiology 146,3081–3090.

Loyse, A., Storring, R.A., and Melzer, M. (2006). Pseudomonas stutzeri pneumonia in an HIV seropositive patient. J. Infect. 53, 75–76.

Lund, H., Nilsson, T.E., and Pickard, T. (1998). Treatment of fabrics. US Patent 60077316 A.

Mao, H.K. (2000). Process for forming highly soluble linear alkyl benzene sulfonate surfactant and cleaning compositions containing the same. WO/2000/040551 A1. 

Martel, C., Nielsen, G.D., Mari, E., Licht, T.R., and Poulsen, L.K. (2010). Scientific / Technical Report Submitted to EFSA - Bibliographic Review on the Potential of Microorganisms, Microbial Products and Enzymes to Induce Respiratory Sensitization. CFP/EFSA/FEEDAP/2009/02.http://www.efsa.europa.eu/en/supporting/pub/75e.htm (viewed July 2012).

Martins, C.A., Alvito, P., Tavares, M.J., Pereira, P., Doucaette, G., and Franca, S. (2003). Reevaluation of Production of Paralytic Shellfish Toxin by Bacteria Associated with Dinoflagellates of the Portuguese Coast. Appl. Environ. Microbiol. 69, 5693–5698.

Meier, P., and Wackernagel, W. (2005). Impact of mutS inactivation on foreign DNA acquisition by natural transformation in Pseudomonas stutzeri. J. Bacteriol. 187,143–154.

Meier, P., and Wackernagel, W. (2003). Mechanisms of homology-facilitated illegitimate recombination for foreign DNA acquisition in transformable Pseudomonas stutzeri. Mol. Microbiol. 48(4), 1107–1118.

Meyer, J.M., and Abdallah, M.A. (1980). The siderochromes of non-fluorescent pseudomonads: Production of nocardamine by Pseudomonas stutzeri. J. Gen. Microbiol. 118,125–129.

Mikkelsen, M., Ryom, N.M., Ladefoged, C., and Friis-Jensen, S. (2012). Detergent compositions and the use of enzyme combinations therein. US Patent 8329632 B2.

Miron, D., Keness, Y., Bor, N., Spiegel, R., and Horowitz, Y. (2007). Pseudomonas stutzeri knee arthritis in a child: Case report and review. J. Pediatr. Orthop. B 16,419–421.

NCPPB. (2013). National Collection of Plant Pathogenic Bacteria No. 1972. Pseudomonas stutzeri (Lehmann & Neumann 1896) Sijderius 1946. http://www.straininfo.net/strains/18629/browser;jsessionid=57D3C894060B0C0DD7F0514EC1BFDC93 [viewed May 2013]. 

Noble, R.C., and Overman, S.B. (1994). Pseudomonas stutzeri Infection: A Review of Hospital Isolates and a Review of the Literature. Diagn. Microbiol. Infect. Dis. 19,51–56.

Palleroni, N.J. (2005). Genus 1: Pseudomonas Migula 1894. In Bergey's Manual of Systematic Bacteriology. Volume 2 The Proteobacteria. Part B. Brenner, D. J., Krieg, N. R. and Staley, J. T. eds., (New York: Springer) pp. 355–373.

Palleroni, N.J., Doudoroff, M., Stanier, R.Y., Solánes, R.E., and Mandel, M. (1970). Taxonomy of the aerobic pseudomonads: the properties of the Pseudomonas stutzeri group. J. Gen. Microbiol. 60, 215–231.

Pandey, R., Chavan, P.N., Walokar, N.M., Sharma, N., Tripathi, V., and Khetmalas, M.B. (2013). Pseudomonas stutzeri RP1: A Versatile Plant Growth promoting Endorhizospheric Bacteria inhabiting Sunflower (Helianthus annus). . Res J Biotechnol 8(7), 48–55.

Plumely, F.G., Wei, Z., and Toivanen, T.B. (1999). Tn5 Mutagenesis of Pseudomonas stutzeri SF/PS, A Bacterium Associated with Alexandrium lusitanicum (Dinophyceae) and Paralytic Shellfish Poisoning. J. Phycol. 35, 1396.

Podgorsek, L., and Imhoff, J.F. (1999). Tetrathionate production by sulfur oxidizing bacteria and the role of tetrathionate in the sulfur cycle of Baltic Sea sediments. Aquatic Microb. Ecol. 17, 255–265.

Poirel, L., Rodríguez-Martínez, J.-., Al Naiemi, N., Debets-Ossenkopp, Y.J., and Nordmann, P. (2010). Characterization of DIM-1, an integron-encoded metallo-β-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands. Antimicrob. Agents Chemother. 54, 2420–2424.

Potvliege, C., Jonckheer, J., Lenclud, C., and Hansen, W. (1987). Pseudomonas stutzeri pneumonia and septicemia in a patient with multiple myeloma. J. Clin. Microbiol. 25,458–459.

Priestley, G.S., Holland, J., Marsh, B., and Wilson, R. (1996). Pseudomonas stutzeri septicaemia in association with a bullous skin eruption. Anaesth. Intensive Care 24,710–713.

Product Sheet A (2012). Advance Water Technologies Material Safety Data Sheet: Powder-Based Bacterial Mixture (Includes the following brand name formulations: StartSmart Activator, PondPerfect Activator, PitMaster Activator, OdorMaster Activator, EcoBac, EcoClear, Septic Medic Power Pack, and EcoSock http://awtech.ca/home/wp-content/uploads/2013/06/Advanced-Water-Technologies-MSDS-Powder-Based-Bacterial-Products.pdf (viewed June 2013).

Product Sheet B (2012). TLC Products Material Safety Data Sheet: Powder Based Bacterial Mixture (Includes the following brand-name formulations: StartSmart Activator, PondPerfect Activator, PitMaster Activator, OdorMaster Activator, EcoBac, EcoClear, Septic Medic Power Pack, and EcoSock. http://tlcproducts.com (viewed June 2013).

Product Sheet C (2013). Blue Planet Indochina Certificate of Analysis: Aqua Clean ACF 32. http://www.blueplanetindochina.com/img/MediaRoom/41.pdf (viewed June 2013).

Product Sheet D (2009). Bio-Industries Ltd. Material Safety Data Sheet: Bioegreaser.  http://www.bio.com.tr/doc/en/BioYagCozucuMGBFEN.pdf  (viewed June 2013).

Product Sheet E (2013). Organica Product Brochure: Formula 33. http://www.organica-uk.co.uk/pdfdownloads/wastewater.pdf (viewed June 2013).

Product Sheet F (2013). YLAD Living Soils Product Brochure: Nutri-Life 4/20. http://www.yladlivingsoils.com.au/OurProducts/Microbials/nutri-life-420.html (viewed June 2013).

Product Sheet G (2013) CLEA Technologies. (2013). Product Brocure: Soluble Lipase. http://v2.sparqcms.com/dir_upload/site/e5ba009256c49070f8b73bba45df96ee/PS_FE_Lipase.pdf  (viewed June 2013).

Rainey, P.B., Thompson, I.P., and Palleroni, N.J. (1994). Genome and fatty acid analysis of Pseudomonas stutzeri. Int. J. Syst. Bacteriol. 44, 54-61.

Rediers, H., Bonnecarrère, V., Rainey, P.B., Hamonts, K., Vanderleyden, J., and De Mot, R. (2003). Development and Application of a dapB-Based in Vivo Expression Technology System to Study Colonization of Rice by the Endophytic Nitrogen-Fixing Bacterium Pseudomonas stutzeri A15. Appl. Environ. Microbiol. 69, 6864–6874.

Reniero, D., Mozzon, E., Galli, E., and Barbieri, P. (1998). Two aberrant mercury resistance transposons in the Pseudomonas stutzeri plasmid pPB. Gene. 208, 37–42.

Reisler, R.B., and Blumberg, H. (1999). Community-acquired Pseudomonas stutzeri vertebral osteomyelitis in a previously healthy patient: Case report and review. Clin. Infect. Dis. 29, 667–669.

Ring, J., Abeck, D., and Neuber, K. (1992). Atopic eczema: Role of microorganisms on the skin surface. Allergy Eur. j. Allergy Clin. Immunol. 47, 265–269.

Roig, P., Orti, A., and Navarro, V. (1996). Meningitis due to Pseudomonas stutzeri in a patient infected with human immunodeficiency virus. Clin. Infect. Dis. 22,587–588.

Rosenberg, I., Leibovici, L., and Mor, F. (1987). Pseudomonas stutzeri causing late prosthetic valve endocarditis. J. R. Soc. Med. 80, 457–459.

Rosselló-Mora, R., and Amann, R. (2001).The species concept for prokaryotes. FEMS Microbiol. Rev. 25(1), 39–67.

Rosselló, R., Garcia-Valdes, E., Macario, A.J.L., Lalucat, J., and Conway de Macario, E. (1992). Antigenic Diversity of Pseudomonas stutzeri. System. Appl. Microbiol. 15, 617–623.

Rosselló, R., Garcia-Valdes, E., Lalucat, J., and Ursing, J. (1991). Genotypic and phenotypic diversity of Pseudomonas stutzeri. Syst. Appl. Microbiol. 14, 150–158.

Rowley, A.H., Dias, L.D., Chadwick, E.G., and Shulman, S.T. (1987). Pseudomonas stutzeri: An unusual cause of calcaneal Pseudomonas osteomyelitis. Pediatr. Infect. Dis. J. 6, 296–297.

Rius, N., Carme Fusté, M.C., Guasp C., Lalucat, J., and Lorén, J.G. (2001). Clonal population structure of Pseudomonas stutzeri, a species with exceptional genetic diversity. J. Bacteriol. 183(2), 736–744.

Sazinsky, M.H., Bard, J., Di Donato, A., and Lippard, S.J. (2004). Crystal structure of the toluene/o-xylene monooxygenase hydroxylase from Pseudomonas stutzeri OX1: Insight into the substrate specificity, substrate channeling, and active site tuning of multicomponent monooxygenases. J. Biol. Chem. 279, 30600–30610.

Scotta, C., Mulet, M., Sánchez, D., Bennasar, A., García-Valdés, E., Lalucat, J., Gomila, M., Ramírez, A., Bennasar, A., García-Valdés, E., Lalucat, J., and Holmes, B. (2012). Identification and genomovar assignation of clinical strains of Pseudomonas stutzeri. Eur. J. Clin. Microbiol. Infect. Dis. 31, 2133–2139.

Scotta C., Gomila, M,, Mulet, M., Lalucat, J., and García-Valdés, E. (2013). Whole-cell MALDI-TOF mass spectrometry and multilocus sequence analysis in the discrimination of Pseudomonas stutzeri populations: three novel genomovars. Microb. Ecol. 66, 522–532.

Setlow, P. (2006). Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J App. Microbiol. 101, 514–525.

Sikorski, J., Lalucat, J., and Wackernagel, W. (2005). Genomovars 11 to 18 of Pseudomonas stutzeri, identified among isolates from soil and marine sediment. Int. J. Syst. Evol. Microbiol. 55, 1767–1770.

Sikorski, J., Möhle, M., and Wackernagel, W. (2002). Identification of complex composition, strong strain diversity and directional selection in local Pseudomonas stutzeripopulations from marine sediment and soils. Environ. Microbiol. 4, 465–476.

Sikorski, J., Rosselló-Mora, R., and Lorenz, M.G. (1999). Analysis of genotypic diversity and relationships among Pseudomonas stutzeri strains by PCR-based genomic fingerprinting and multilocus enzyme electrophoresis. Syst. Appl. Microbiol. 22, 393–402.

Silva, E., Fialho, A.M., Correia, I.SA, Burns, R.G. and Shaw, L.J. (2004). Combined bioaugmentation and biostimulation to cleanup soil contaminated with high concentrations of atrazine. Environ. Sci. Technol. 38:632–637.

Silvanose, C.D., Bailey, T.A, Naldo, J.L and Howlett, J.C. (2001). Bacterial flora of the conjunctiva and nasal cavity in normal and diseased captive bustards. Avian Diseases. 45: 447–451.

Silverman, J.M., Brunet, Y.R., Cascales, E., and Mougous, J.D. (2012). Structure and regulation of the type VI secretion system. Annu. Rev. Microbiol. 66, 453–472.

Singh, R., Stine, O.C., Smith, D.L., Spitznagel Jr., J.K., Labib, M.E., and Williams, H.N. (2003). Microbial diversity of biofilms in dental unit water systems. Appl. Environ. Microbiol. 69, 3412–3420.

Sorokin, D.Y., Teske, A., Robertson, L.A., and Kuenen, J.G. (1999). Anaerobic oxidation of thiosulfate to tetrathionate by obligately heterotrophic bacteria, belonging to the Pseudomonas stutzeri group. FEMS Microbiol. Ecol. 30,113–123.

Stackebrandt, E., Frederiksen, W., Garrity, G.M., Grimont, P.A., Kämpfer, P., Maiden, M.C., Nesme, M., Rosselló-Mora, R., Swings, J., Truper, H.G., Vauterin, L., Ward, A.C., and Whitman, W.B. (2002). Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology. Int. J.Syst. Evol. Microbiol. 52(3), 1043–1047.

Stanier, R.Y., Palleroni, N.J., and Doudoroff, M. (1966). The Aerobic Pseudomonads: a Taxonomic Study. J. Gen. Microbiol. 43, 159–271.

Tattawasart, U., Hann, A.C., Maillard, J.Y., Furr, J.R., and Russell, A.D. (2000). Cytological changes in chlorohexidine-resistant isolates of Pseudomonas stutzeri. J. Antimicrob. Chemoth. 45, 145–152.

Tattawasart, U., Maillard, J.Y., Furr, J.R., and Russell, A.D. (1999). Development of resistance to chlorohexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J. Hosp. Infect. 42,219–229.

Tetu, S.G., and Holmes, A.J. (2008). A family of insertion sequences that impacts integrons by specific targeting of gene cassette recombination sites, the IS1111-attC group. J. Bacteriol. 190, 4959–4970.

The Uniprot Consortium. (2013). Update on activities at the Universal Protein Resource (UniProt) in 2013. Nucleic Acids Res 41, D43-D47. http://www.uniprot.org (viewed July 2013).

Ude, S., Arnold, D.L., Moon, C.D., Timms-Wilson, T., and Spiers, A.J. (2006). Biofilm formation and cellulose expression among diverse environmental Pseudomonas isolates. Environ. Microbiol. 8, 1997–2011.

Utagawa, T., Miyoshi, T., Yoshinaga, F., Mitsugi, K., Morisawa, H., and Yamazaki, A. (1982). Method for producing purine arabinosides. CIPO 1120876.

Van Niel, C.B., and Allen, M.B. (1952). A note on Pseudomonas stutzeri. J. Bacteriol. 64,413–422.

Van Veen, J.A., Van Overbeek, L.S., and Van Elsas, J.D. (1997). Fate and activity of microorganisms introduced into soil. Microbiol. Mol. Biol. Rev. 61, 121–135.

Velayutham, T., Arutchelvan, V., Nagarajan, S., and Muralikrishnan, V. (2012). Isolation and identification of polycyclic aromatic hydrocarbon-degrading bacteria from crude oil exploration bore well sludge. Biorem. J. 16,141–146.

Wencewicz, T.A., Long, T.E., Mollmann, U., and Miller, M.J. (2013). Trihydroxamate Siderophore–Fluoroquinolone Conjugates Are Selective Sideromycin Antibiotics that Target Staphylococcus aureus. Bioconjugate Chem. 24(3), 473–486.

White, A.K., and Metcalf, W.W. (2004). Two C-P lyase operons in Pseudomonas stutzeri and their roles in the oxidation of phosphonates, phosphite, and hypophosphite. J. Bacteriol. 186, 4730–4739.

Winsor, G.L., Lam, D.K.W., Fleming, L., Lo, R., Whiteside, M.D., Yu, N.Y., Hancock, R.E.W., and Brinkman, F.S.L. (2011). Pseudomonas Genome Database: improved comparative analysis and population genomics capability for Pseudomonas genomes. Nucleic Acids Res. 39, D596–D600.

Xiang, S.-., Cook, M., Saucier, S., Gillespie, P., Socha, R., Scroggins, R., and Beaudette, L.A. (2010). Development of amplified fragment length polymorphism-derived functional strain-specific markers to assess the persistence of 10 bacterial strains in soil microcosms. Appl. Environ. Microbiol. 76, 7126–7135.

Yamamoto, S., Ksai, H.,  Arnold, D. L., Jackson, R. W., Vivian, A., and Harayama, S. (2000). Phylogeny of the genus Pseudomonas: intrageneric structure reconstructed from the nucleotide sequences of gyrB and rpoD genes. Microbiol. 146, 2385–2394.

Yan, J., Hsueh, P., Ko, W., Luh, K., Tsai, S., Wu, H., and Wu, J. (2001). Metallo-β-lactamases in clinical Pseudomonasisolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45,2224–2228.

Yan, Y., Yang, J., Dou, Y., Chen, M., Ping, S., Peng, J., Lu, W., Zhang, W., Yao, Z., Li, H., et al. (2008). Nitrogen fixation island and rhizosphere competence traits in the genome of root-associated Pseudomonas stutzeri A1501. Proc. Natl. Acad. Sci. U. S. A. 105, 7564–7569.

Yee-Guardino, S., Danziger-Isakov, L., Knouse, M., Bingaman, W., Sabella, C., and Goldfarb, J. (2006). Nosocomially acquired Pseudomonas stutzeri brain abscess in a child: Case report and review. Infect. Cont. Hosp. Ep. 27, 630–632.

Zumft, W.G., Viebrock-Sambale, A., and Braun, C. (1990). Nitrous oxide reductase from denitrifying Pseudomonas stutzeri. Genes for copper-processing and properties of the deduced products, including a new member of the family of ATP/GTP-binding proteins. Eur. J. Biochem. 192, 591–599.

Top of Page

Appendix A: Characterization P. stutzeriATCC 17587

Table A-1: Colony morphology of Pstutzeri ATCC 17587 on nutrient agar at various temperatures and incubation periods
CharacteristicFootnote Appendix A Table A1[a] Nutrient agar (ATCC)
37°C 24 h
Nutrient agar
28°C 24 h
Nutrient agar
28°C 48 h
Nutrient agar
37°C 24 h
Nutrient agar
37°C 48 h
Size 0.5 mm 0.5 mm a) 2 mm
b) 11 mm
a) 1 mm
b) 10 mm
a) 4 mm
b) 25 mm
Form a) circular
b) irregular rhizoid
circular a) circular
b) circular
a) circular
b) irregular
a) circular
b) circular
Elevation a) convex
b) raised
no data flat flat flat
Margin a) entire no data a) entire
b) filiform
entire a) imperfect entire
b) filiform
Surface a) smooth no data a) moist
b) spongy
a) smooth
b) spongy
a) umbonate
b) spongy
Opacity a) translucent
b) translucent
no data a) semi-translucent
b) translucent
a) opaque
b) semi-translucent
a) semi-translucent
b) translucent
Chromogenesis colourless colourless colourless colourless colourless
Comments 2 phenotypes too small to discern detail 2 phenotypes 2 phenotypes 2 phenotypes
Table A-2: Colony morphology of P. stutzeri ATCC 17587 on Tryptic Soy Broth (TSB) at various temperatures and incubation periods
CharacteristicFootnote Appendix A Table A2[a] TSB
28°C 24 h
TSB
28°C 48 h
TSB
RT 7 d
TSB
37°C 24 h
TSB
37°C 48 h
Size 0.5 mm 2–3 mm 5 mm 1-3 mm a) 3 mm
b)11 mm
Form circular circular circular - irregular circular a) circular
b) irregular
Elevation no data flat raised - convex - umbonate flat raised
Margin no data entire entire-undulate entire a) entire
b) undulate
Surface no data moist moist small smooth
larger and wrinkled
a) moist
b) dry and winkled
Opacity no data semi-translucent opaque transparent semi-translucent
Chromogenesis no data colourless tan-gold, beige
non fluorescent
colourless light tan, beige
Comments too small to discern detail none non fluorescent 2 phenotypes 2  phenotypes
Table A-3: Growth of P. stutzeriATCC 17587 in liquid media at various temperature
Medium 28°C 32°C 37°C 42°C
Tryptic Soy Broth + + + +
Sheep Plasma ~ ~ ~ -
Fetal Bovine Serum + + + ~
Dulbecco’s Modified Eagles Medium (mammalian cell culture) v - - -
Table A-4: Growth characteristics of Pstutzeri on solid media at 37°C
Medium 37°C
Nutrient +
Growth on Starch Footnote Appendix A Table A4[a] +
Starch Hydrolysis [a] +
Maconkey Agar Footnote Appendix A Table A4[b] -
Lysine Iron Footnote Appendix A Table A4[c] + (no lysine decarboxylase detected)
Triple Sugar Iron - w phenol red Footnote Appendix A Table A4 [d] + (no gas, no hydrogen sulfide detected)
Mannitol Egg Yolk Polymyxin supplements Footnote Appendix A Table A4 [e] -
Mannitol Salt Agar Footnote Appendix A Table A4[f] -
Citrate Footnote Appendix A Table A4[g] -
Urea Footnote Appendix A Table A4[h] + (no urea hydrolysis)

Figure A-1: Fatty Acid Methyl Ester (FAME) Analysis of P. stutzeri ATCC 17587 using MIDI TSBA50 Environmental Database

Figure A-1 (See long description below)
Long description for Figure A-1

Figure A-1 shows the relatedness of DSL strain P. stutzeri ATCC 17587 to nine Pseudomonas species (P. stutzeri, P. resinovorans, P. balearica, P. alcaligenes, P. aeruginosa, P. putida, P. fluorescens, P. taertolens, and P. mandeii) and Neisseria mucosa based on cellular fatty acid composition. The dendrogram shows that the DSL P. stutzeri strain is more closely related to another strain of P. stutzeri, P. resinovoarans, P. balearica, P. alcaligenes, N. mucosa and P. aeruginosa, than to P. fluorescens and P. putida.

Data generated by Heath Canada’s Environmental Health Science and Research Bureau

Figure A-1 shows the relatedness of DSL strain P. stutzeri ATCC 17587 to nine Pseudomonasspecies (P. stutzeri, P. resinovorans, P. balearica, P. alcaligenes, P. aeruginosa, P. putida, P. fluorescens, P. taertolens, and P. mandeii) and Neisseria mucosa according to their cellular fatty acid compositional similarity using GC-FAME and the Sherlock® MIDI Microbial Identification System. Based on the dendrogram, the DSL P. stutzeri strain is more closely related to another strain of P. stutzeri, P. resinovoarans, P. balearica, P. alcaligenes, N. mucosa and P. aeruginosa, than to P. fluorescens and P. putida.

Figure A-2: Fatty Acid Methyl Ester (FAME) Analysis of P. stutzeri ATCC 17587 using MIDI Clinical Database

Figure A-2 (See long description below)
Long description for Figure A-2

Figure A-2 shows the relatedness of DSL strain P. stutzeri ATCC 17587 to P. aeruginosa, P. ligenes, P. alcaligenes, Flavimonas oryzihabitans and Chrymseomonas luteola based on cellular fatty acid composition. The dendrogram shows that the DSL P. stutzeri strain is more closely related to P. ligenes and P. mendocina, than to P. aeruginosa.

Data generated by Heath Canada’s Environmental Health Science and Research Bureau

Figure A-2 shows the relatedness of DSL strain P. stutzeri ATCC 17587 to P. aeruginosa, P. ligenes, P. alcaligenes, Flavimonas oryzihabitans and Chrymseomonas luteola according to their cellular fatty acid compositional similarity using GC-FAME and the Sherlock® MIDI Microbial Identification System. Based on the dendrogram, the DSL P. stutzeri strain is more closely related to P. ligenes and P. mendocina, than to P. aeruginosa.

Top of Page

Appendix B: Select Mobile Elements in P. stutzeri

Select Mobile Elements in P. stutzeri
Mobile elements Strain Characteristic and function Reference
Insertion Sequence ISPst6(4 copies) ATCC 17587
(clinical isolate)
  • recognizable by their imperfect inverted repeat (pseudo-palindrome) structure with two characteristic “flipped-out” positions
  • targets recombination site attC
  • interaction between ISPst6 and attC has been used as a model in investigating evolutionary processes in pseudomonads
Tetu and Holmes, 2008
Insertion Sequence ISPst9 CCUG 29243
(marine isolate)
  • catabolic gene inactivation of naphthalene pathway
Christie-Oleza et al., 2008
Insertion Sequence ISPs1 OX1
(sludge isolate)
  • catabolic gene inactivation of meta and para-xylene pathways
Bolognese et al., 1999
Class 1 Integron

ATCC 17588
(clinical isolate)

CCUG 29243
(marine isolate)

DSM 10701
(soil isolate)

DSM 4166
(soil isolate)

CCBH 4919
(clinical isolate)

  • contains blaIMP-16 gene
  • codes for imipenemase-type metallo-β-lactamases that catalyze the hydrolysis of a broad range of β-lactams, including carbapenem
  • possibly acquired under selective pressure of antibiotic exposure in the hospital environment

Winsor et al., 2011
The Uniprot Consortium

Lee et al., 2004
Carvalho-Assef et al., 2010
Yan et al., 2001

Tn501-like transposon OX1
(environmental isolate)
  • organo-mercury detoxification through the activity of mercuric reductase (merA)
Reniero et al., 1998
Figure 1-2 (See long description below)
Figure A-1 (See long description below)
Figure A-2 (See long description below)
Figure 1-2 (See long description below)
Figure A-1 (See long description below)
Figure A-2 (See long description below)

Page details

Date modified: